Google NewsOsteopore (ASX:OSX) signs 3-year GCC deal targeting a US$1.55bn orthopaedic market - Stocks Down Under
Osteopore (ASX:OSX) signs 3-year GCC deal targeting a US$1.55bn orthopaedic market Stocks Down Under
Osteopore (OSX) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXOSX strikes orthopaedic deal for 5 Middle East countries
other announcement
OSX completes first Hainan custom orthopaedic implant
other announcement
First OSX custom orthopaedic implant delivered to Hainan
other announcement
OSX & Zimmer gain craniofacial market access to Saudi Arabia
other announcement
OSX completes co-development project for neurosurgical guide
other announcement
First patient treated in OSX-PAH jaw reconstruction trial
other announcement
First 2 patients treated in QCH cleft lip clinical trial
other announcement
Osteopore (ASX: OSX): Could Medtech Stock OSX Be an Undiscovered Growth Story? - Kalkine
Osteopore (ASX: OSX): Could Medtech Stock OSX Be an Undiscovered Growth Story? Kalkine
QCH cleft lip clinical study patient recruitment completed
other announcement
OSX neuro products approved in a major centre in Thailand
other announcement
Notification regarding unquoted securities - OSX
other announcement
Further Drawdown of T2 of the Redeemable Convertible Notes
other announcement
First OSX custom orthopaedic implant completed in Hong Kong
other announcement
OSX & DKSH Malaysia dental launch First products delivered
other announcement
KalkineOsteopore’s New Share Issue Signals Focus on Future Growth
Highlights Osteopore has applied for quotation of more than fifty-two million new ordinary shares on the ASX. The expanded share base may improve market liquidity and support future business initiatives. The capital markets activity reflects the company's ongoing focus on commercialising regenerative medical technologies. Osteopore has applied to quote more than fifty-two million new shares on the ASX, strengthening its capital position as it continues commercialising regenerative medical tec...
OSX & QCH launch trial for nasoalveolar augment in children
other announcement
Osteopore (ASX:OSX) shares rise by 50% as it cracks the Chinese market - Stocks Down Under
Osteopore (ASX:OSX) shares rise by 50% as it cracks the Chinese market Stocks Down Under
OSX secures Hainan FDA approval for orthopaedic devices
other announcement
Osteopore (ASX:OSX) is set to crack the Malaysian market - and its bigger than you may think! - Stocks Down Under
Osteopore (ASX:OSX) is set to crack the Malaysian market - and its bigger than you may think! Stocks Down Under
OSX orthopaedic products gain Malaysian market access rights
other announcement
Notification regarding unquoted securities - OSX
other announcement
Further Drawdown of T2 of the Redeemable Convertible Notes
other announcement
Clarification - agreement for injectable regen bone filler
other announcement
OSX signs agreement for injectable regenerative bone filler
other announcement
OSX and NUH to co-develop surgical guide in neurosurgery
other announcement
OSX and TTSH sign collaboration agreement for novel implant
other announcement